We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

ERBA MANNHEIM

Erba Mannheim is an IVD solutions provider focused on improving health outcomes in developing nations. Originally fou... read more Featured Products: More products

Download Mobile App





Erba Mannheim Showcases Exciting New Introductions at MEDLAB Middle East 2021

By LabMedica International staff writers
Posted on 22 Jun 2021
Print article
Illustration
Illustration
Erba Mannheim (London, UK) showcased some of its exciting new introductions at MEDLAB Middle East 2021, the MENA region’s largest medical laboratory exhibition and congress, which took place at the Dubai World Trade Centre from 21-24 June.

Erba introduced the fully automated ELAN 30s, a complete solution for lab ELISA workflow that allows users to develop new, flexible analytical workflows by taking advantage of smart scheduling software. By combining up to six different assays in a single run users can break the traditional two or four plate mold and create ‘clinical panel’ based workflows. Multiple reporting formats enhance the final steps of the process and allow the user to report faster with more convenience.

Erba also exhibited its new hematology analyzers - the H360 automated 3 part differential analyzer and H560 automated 5 part differential hematology analyzer, alongside the Elite 580 automated 5-part hematology analyzer with continuous loading capacity. Also on display at this year’s MEDLAB Middle East 2021 edition was the LAURA XL fully automated urine analyzer that combines urine strip reading with digital microscopy. The two-module integrated station consists of one module which performs analysis of the chemical parameters of urine on diagnostic test strips using reflective photometry; and one module performs urinary sediment examination using automated microscopy technology in a format compatible with manual microscopy. In addition, Erba showcased the next generation electrolyte analyzer, EC 90 ISE, which employs cutting edge technology to take laboratory electrolyte measurements to new heights. The EC 90 electrolyte analyzer features next generation thick film, maintenance-free electrodes in all-in-one sensor cartridge.

Alongside these new products, the company presented the ErbaMDx SARS-COV-2 RT-PCR kit, a molecular diagnostic test that aids the detection and diagnosis of COVID-19 infections and is based on latest nucleic acid amplification technologies. It is a real-time reverse transcriptase PCR test that has been developed utilizing universally trusted priming sites with updated primer sequences to maximize long term performance.

Related Links:
Erba Mannheim

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.